<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(10)</volume><submitter>Chim SM</submitter><funding>Regeneron Pharmaceuticals, Inc.</funding><pubmed_abstract>&lt;b>Background/Objectives:&lt;/b> The limited translatability of preclinical experimental findings to patients remains an obstacle for successful treatment of brain diseases. Relevant models to elucidate mechanisms behind brain pathogenesis, including cell-specific contributions and cell-cell interactions, and support successful targeting and prediction of drug responses in humans are urgently needed, given the species differences in brain and blood-brain barrier (BBB) functions. Human microphysiological systems (MPS), such as Organ-Chips, are emerging as a promising approach to address these challenges. Here, we examined and advanced a Brain-Chip that recapitulates aspects of the human cortical parenchyma and the BBB in one model. &lt;b>Methods:&lt;/b> We utilized human primary astrocytes and peric</pubmed_abstract><journal>Pharmaceutics</journal><pagination>1314</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11510380</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood-Brain Barrier Crossing Therapeutic Strategies.</pubmed_title><pmcid>PMC11510380</pmcid><pubmed_authors>Zambrowicz B</pubmed_authors><pubmed_authors>Chim SM</pubmed_authors><pubmed_authors>Karalis K</pubmed_authors><pubmed_authors>Howell K</pubmed_authors><pubmed_authors>Kokkosis A</pubmed_authors><pubmed_authors>Pavlopoulos E</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood-Brain Barrier Crossing Therapeutic Strategies.</name><description>&lt;b>Background/Objectives:&lt;/b> The limited translatability of preclinical experimental findings to patients remains an obstacle for successful treatment of brain diseases. Relevant models to elucidate mechanisms behind brain pathogenesis, including cell-specific contributions and cell-cell interactions, and support successful targeting and prediction of drug responses in humans are urgently needed, given the species differences in brain and blood-brain barrier (BBB) functions. Human microphysiological systems (MPS), such as Organ-Chips, are emerging as a promising approach to address these challenges. Here, we examined and advanced a Brain-Chip that recapitulates aspects of the human cortical parenchyma and the BBB in one model. &lt;b>Methods:&lt;/b> We utilized human primary astrocytes and peric</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-04T03:03:45.807Z</modification><creation>2025-04-04T03:03:45.807Z</creation></dates><accession>S-EPMC11510380</accession><cross_references><pubmed>39458643</pubmed><doi>10.3390/pharmaceutics16101314</doi></cross_references></HashMap>